T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission

Little information is available regarding late relapse in patients with T-lymphoblastic leukemia/lymphoma (T-LBL). Because of the aggressive nature of this disease, relapse is common and often happens early. Late relapses are rare and generally occur within a few years after initial remission. The r...

Descripción completa

Detalles Bibliográficos
Autores principales: Elreda, Lauren, Sandhu, Manpreet, Sun, Xinlai, Bekele, Wondwessen, Cohen, Alice J., Shah, Maya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005062/
https://www.ncbi.nlm.nih.gov/pubmed/24822133
http://dx.doi.org/10.1155/2014/359158
_version_ 1782314056655306752
author Elreda, Lauren
Sandhu, Manpreet
Sun, Xinlai
Bekele, Wondwessen
Cohen, Alice J.
Shah, Maya
author_facet Elreda, Lauren
Sandhu, Manpreet
Sun, Xinlai
Bekele, Wondwessen
Cohen, Alice J.
Shah, Maya
author_sort Elreda, Lauren
collection PubMed
description Little information is available regarding late relapse in patients with T-lymphoblastic leukemia/lymphoma (T-LBL). Because of the aggressive nature of this disease, relapse is common and often happens early. Late relapses are rare and generally occur within a few years after initial remission. The relapse rate after 3 years has been reported to steadily decrease over time yet does not parallel with cure. We report a case of a 26-year-old female with T-LBL and relapse 16 years after her first remission with successful treatment with HyperCVAD and L-asparaginase.
format Online
Article
Text
id pubmed-4005062
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40050622014-05-12 T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission Elreda, Lauren Sandhu, Manpreet Sun, Xinlai Bekele, Wondwessen Cohen, Alice J. Shah, Maya Case Rep Hematol Case Report Little information is available regarding late relapse in patients with T-lymphoblastic leukemia/lymphoma (T-LBL). Because of the aggressive nature of this disease, relapse is common and often happens early. Late relapses are rare and generally occur within a few years after initial remission. The relapse rate after 3 years has been reported to steadily decrease over time yet does not parallel with cure. We report a case of a 26-year-old female with T-LBL and relapse 16 years after her first remission with successful treatment with HyperCVAD and L-asparaginase. Hindawi Publishing Corporation 2014 2014-04-14 /pmc/articles/PMC4005062/ /pubmed/24822133 http://dx.doi.org/10.1155/2014/359158 Text en Copyright © 2014 Lauren Elreda et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Elreda, Lauren
Sandhu, Manpreet
Sun, Xinlai
Bekele, Wondwessen
Cohen, Alice J.
Shah, Maya
T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_full T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_fullStr T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_full_unstemmed T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_short T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
title_sort t-cell lymphoblastic leukemia/lymphoma: relapse 16 years after first remission
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005062/
https://www.ncbi.nlm.nih.gov/pubmed/24822133
http://dx.doi.org/10.1155/2014/359158
work_keys_str_mv AT elredalauren tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT sandhumanpreet tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT sunxinlai tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT bekelewondwessen tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT cohenalicej tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission
AT shahmaya tcelllymphoblasticleukemialymphomarelapse16yearsafterfirstremission

Ejemplares similares